Background. Probabilistic sensitivity analyses (PSA) may lead policy makers to take nonoptimal actions due to misestimates of decision uncertainty caused by ignoring correlations. We developed a method to establish joint uncertainty distributions of quality-of-life (QoL) weights exploiting ordinal preferences over health states. Methods. Our method takes as inputs independent, univariate marginal distributions for each QoL weight and a preference ordering. It establishes a correlation matrix between QoL weights intended to preserve the ordering. It samples QoL weight values from their distributions, ordering them with the correlation matrix. It calculates the proportion of samples violating the ordering, iteratively adjusting the correlation matrix until this proportion is below an arbitrarily small threshold. We compare our method with the uncorrelated method and other methods for preserving rank ordering in terms of violation proportions and fidelity to the specified marginal distributions along with PSA and expected value of partial perfect information (EVPPI) estimates, using 2 models: 1) a decision tree with 2 decision
Background. Probabilistic sensitivity analyses (PSA) may lead policy makers to take nonoptimal actions due to misestimates of decision uncertainty caused by ignoring correlations. We developed a method to establish joint uncertainty distributions of quality-of-life (QoL) weights exploiting ordinal preferences over health states. Methods. Our method takes as inputs independent, univariate marginal distributions for each QoL weight and a preference ordering. It establishes a correlation matrix between QoL weights intended to preserve the ordering. It samples QoL weight values from their distributions, ordering them with the correlation matrix. It calculates the proportion of samples violating the ordering, iteratively adjusting the correlation matrix until this proportion is below an arbitrarily small threshold. We compare our method with the uncorrelated method and other methods for preserving rank ordering in terms of violation proportions and fidelity to the specified marginal distributions along with PSA and expected value of partial perfect information (EVPPI) estimates, using 2 models: 1) a decision tree with 2 decision alternatives and 2) a chronic hepatitis C virus (HCV) Markov model with 3 alternatives. Results. All methods make tradeoffs between violating preference orderings and altering marginal distributions. For both models, our method simultaneously performed best, with largest performance advantages when distributions reflected wider uncertainty. For PSA, larger changes to the marginal distributions induced by existing methods resulted in differing conclusions about which strategy was most likely optimal. For EVPPI, both preference order violations and altered marginal distributions caused existing methods to misestimate the maximum value of seeking additional information, sometimes concluding that there was no value. Conclusions. Analysts can characterize the joint uncertainty in QoL weights to improve PSA and value-of-information estimates using Open Source implementations of our method. Key words: probabilistic sensitivity analysis; joint distribution; parameter correlation; value of information; expected value of partial perfect information; bias; correlated parameters. (Med Decis Making 2016;36:927-940) S tandard assessments of decision uncertainty may lead risk-averse policy makers to take nonoptimal actions because they imply incorrectly high or low levels of certainty about model-based recommendations. 1 This results from 2 important types of information derived from decision-analytic models and how this information is generated. First, models provide estimates of expected health benefits and costs for each alternative to identify the most cost-effective for implementation. 2 Second, through probabilistic sensitivity analyses (PSAs), models assess how uncertain this recommendation is and gauge the expected value of obtaining additional information (VOI). [3] [4] [5] [6] While accurate point estimates of model inputs permit accurate cost-effectiveness assessments, estimates of decision uncertainty may still be biased depending on how the PSA and VOI are conducted. 3, 7 Although PSAs are mostly governed by standard practices, 3, 8 important methodological issues remain. Specifically, estimates of decision uncertainty from PSAs are only as good as the assumptions made about the joint uncertainty of a model's inputs. [9] [10] [11] [12] In practice, PSAs typically assume independence among the inputs' uncertainty distributions, enabling the use of univariate, parametric distributions. 8 In some instances, correlations between the uncertainty distributions of specific model inputs-mainly related to disease natural history or test characteristics-can be obtained via methods such as empirical model calibration. [13] [14] [15] [16] [17] [18] However, without substantial primary data, methods to establish the joint uncertainty distributions of other major categories of model inputs (e.g., treatment efficacies, side effects, and adherence, costs, quality-adjusted life years [QALY] weights, etc.) remain challenging, a situation that previous authors have acknowledged. 3, 10, 14, 16, 17, [19] [20] [21] [22] [23] Our study develops a practical method for establishing the joint uncertainty distribution of quality-of-life (QoL) weights for a set of health states. Our method exploits the fact that while one may only have point estimates and confidence intervals to infer the uncertainty describing the QoL weight of each health state, additional information regarding their joint uncertainty distribution can be recovered by using the ordinal preferences over these health states. Without such correlations in QoL weight uncertainties, more severe health states such as cancer may be valued as being better than near-perfect health-a situation whose falsehood is a certainty.
METHODS
We describe a method for using health state preference orderings to reduce the bias in PSAs and VOI analyses. First, we review existing approaches and assess them with respect to ideal properties that such methods should have. We then describe our method and compare the performance of each method using both a simple, illustrative decision model and a more complex, previously published Markov model. 24 
Problem Definition
The joint uncertainty of QoL weights for health states should preserve the natural preference ordering over those states: 
Existing Methods
In situations where individuals' QoL weight assessments for multiple health states are not available, a variety of approaches exist to establish the joint uncertainty distribution for QoL weights. Each makes tradeoffs between achieving various properties, which we would argue an ideal method would simultaneously satisfy the following:
1. preserving the rank order of health states, 2. preserving the marginal (univariate) distributions for each QoL weight consistent with those in the literature, 3. practicality of being simple to define and implement. Table 1 details existing methods that have been applied or proposed and compares them with the ideal properties listed above. 3, 25, 26 None achieves all ideal properties simultaneously.
New Method (Induced Correlations)
The core concept of our approach relies on reducing preference order violations by correlating QoL b. The marginal distribution of U(A) will be consistent, but unless the distributions of U(B) and U(C) have the same distributional shape to that of U(A) and just means that are on average lower and uncertainty that is a multiplicative factor of that of U(A), then the method does not preserve their marginal distributions.
c. The method is relatively simple to define, explain, define, and implement in real-world applications if the distributions of g 1 and g 2 are simple and univariate. If they are complex and joint, then this may not be the case.
weights. However, sampling correlated QoL weights from a joint probability distribution can be extremely difficult. Thus, we first take a large number of independent samples (e.g., 10,000) from the QoL weights' independent marginal distributions-one vector of QoL weight samples per health state. Then, we ''induce'' correlation among these vectors by sorting them using the algorithm described below. Such correlation results in reducing the number of preference order violations without altering the marginal uncertainty distributions. We build up an explanation of our full algorithm step by step. First, we provide intuition about how our sorting algorithm works with a simple numerical example with only 2 vectors of sampled QoL weights for 2 health states. Then, we show how this approach can be extended to handle vectors of sampled QoL weights for more than 2 health states for which we may have more complex preference orderings. Our first example focuses on 2 uncertain QoL weights for 2 hypothetical health states: ''mild complications,'' which is rationally preferred over ''moderate complications.'' We assume that the utility of mild complication is distributed as a beta (9,1) and utility of moderate complication is distributed as beta (8, 2) . The mean utility of mild (0.9) is greater than the mean of utility of moderate (0.8), consistent with our preference order. However, if we treat the uncertainty distributions as independent, it cannot be guaranteed that for all random samples from them, the utility of mild will be greater than moderate.
The columns of step 1 of Table 2 present an example with 10 independent random samples from each distribution as is common in standard PSAs. Both the second and the eighth samples (rows) violate the preference order. Step 1 of Table 2 also shows the rank of the sample within each column vector of QoL weights that play a crucial role in our algorithm. Because of the small sample size in the example, by chance, the 2 utility vectors are correlated at -0.45. Obviously, for a very large sample, the QoL weights and their ranks would be uncorrelated.
To induce correlation between these 2 vectors and thereby eliminate preference order violations, we sort their values according to a multivariate standard normal distribution. The latter distribution acts as a reference distribution because it is relatively easy to sample from, and its correlation structure is easy to specify compared with sampling from other distributions such as correlated ''bi-beta'' distributions.
Step 2 of Table 2 shows 10 random samples taken from a bivariate standard normal distribution with a correlation of 0.9, which represents the correlation we would like to induce between the 2 QoL weight vectors in step 1. We are only interested in the rank ordering of the values from the multivariate normal distribution, not the values themselves. This is because we only use these ranks to sort our original QoL weight samples in step 1 of Table 2 to induce correlation and remove preference order violations as shown in step 3 of Table 2 .
The original values in step 1 of Table 2 are simply rearranged within their respective columns to produce the same rank ordering as the corresponding columns sampled from the correlated multivariate normal distribution (guaranteeing the same rank [Spearman] correlation for both). Notice that by rearranging the values as shown in step 3 of Table 2 , we introduce correlation and avoid preference order violations. Also notice that since we have only sorted the values, we have not changed the marginal distributions in any way. Finally, in the illustrative example, our decision to set the correlation at 0.9 is entirely arbitrary. If we increase the correlation to 1.0, we can guarantee the minimum number of preference order violations, but in doing so, we suggest the uncertainty of one QoL weight is entirely explained by the other, which may not always be the case.
Instead of choosing correlation arbitrarily, we seek to induce a correlation level that balances the uncertainty in the QoL weights and the number of samples that violate the preference ordering. The flowchart in Figure 1 describes an iterative technique of obtaining such correlation. Our starting point in our iterative algorithm is near-perfect correlation between the utility weights because it minimizes the number of violations. First we compute the percentage of samples violating the preference ordering at this level of correlation (r). Then, we incrementally reduce the correlation by a small fixed amount (D). This likely increases the percentage of violations. We do this until the percentage of violations reaches our tolerance threshold (E), at which point we stop, accepting the last correlation level producing preference order violations below E.
Extending the Sorting Algorithm to 3 or More QoL Weights with Complex Preference Orderings
Extending the algorithm above to 3 or more vectors involves 2 additional challenges. First, we may not always have strict preference orderings for every pair of health states. As a result, the preference ordering among the various health states may be more complex than a simple ranking of these states. Thus, sorting multiple utility weights involves obtaining a potentially full correlation matrix. Second, the correlation matrix obtained must have certain mathematical properties that allow multiple utility vectors to be simultaneously sorted. (Below we illustrate a technique to approximate this matrix. In addition, we provide Open Source implementations of our algorithm in both R and MATLAB.)
Step 1: First, we create 3 matrices: 1) a preference order matrix (Q), which defines the preference ordering between each pair of health states; 2) an independent QoL weight matrix (U) whose columns are formed by taking random samples from the independent marginal distribution of each QoL weight; and 3) a reference matrix (R), which has the same dimensions as U but is sampled from an equal number of independent standard normal distributions. We use Q, U, and R in step 2 to construct a matrix U Ã that preserves the independent marginal distributions and has an arbitrarily small number of preference order violations. 1a) Q is an s 3 s matrix, where s is the number of health states. Q permits full flexibility to specify pairwise preferences between health states. The user can express preference orderings for each fj; kg pair of health states, where j 5 f2; :::; sg, and k 5 f1; :::; j À 1g. Thus, Q forms a lower triangular matrix, such that ; where each q j; k takes a value to signify that q j; k 5 1 j th state is preferred over k th state À1 k th state is preferred over j th state 0 there is no strict preference order
< :
See Appendix A for an example constructing a reference matrix Q.
1b) The utility matrix (U) is an n 3 s matrix. Similar to a standard PSA with uncorrelated parameters, this matrix is formed by taking n arbitrary samples from the appropriate independent univariate uncertainty distributions for the QoL weights of each health state. Each column vector of U contains n random QoL weight samples for a particular health state. The columns are clearly uncorrelated. In step 2, we induce correlation among them by sorting them until the preference order violations in U reach a predefined tolerable threshold, if such threshold is attainable.
1c) Before starting the iterative process, we obtain a reference matrix (R). The dimension of R is n 3 s and is formed by taking n random samples from s independent standard normal distributions. We will use R for sorting vectors of U in the steps below.
Step 2: We use an iterative process to calculate the desired correlation matrix (C) that, when used to correlate the vectors of U, will transform it toward achieving the ideal properties described above. If we allow perfect correlations among all utility vectors (i.e., all elements of C set equal to 1), we guarantee the minimum possible preference order violations without altering the marginal distributions. However, with perfect correlation, one can specify uncertainty for only one QoL weight upon which all other QoL weights depend. Therefore, the goal of this step is to find the minimum correlation needed for each pair of QoL weight vectors to preserve the rank ordering set by Q while allowing uncertainty in all QoL weights.
The iterative process consists of 2 loops. An outer loop iterates over all pairs of health states, and an inner loop reduces the correlation coefficient (r) between the selected pair until a tolerable level of violations (E) is reached. We record this correlation, switch to the next pair in the outer loop, and continue until all pairwise correlations are determined. 2a) Outer loop: Let the pair fj; kg represent the selected pair of QoL weight vectors in the outer loop. We set the matrix X equal to the jth and kth column vectors of U and the matrix Y equal to the jth and kth column vectors of R.
2b) Inner loop: In this step, we induce r correlation between the 2 vectors in X. We start with near-perfect correlation (i.e., 1 À D), where D is a small positive quantity (e.g., 0.01). Then, we iteratively decrement r by D until the percent violations reaches the tolerance level (E).
Let S represent a correlation matrix:
Since S is positive and definite, we can express S 5 PP 0 , where P is the lower triangular matrix with the same dimension as S computed using the Cholesky decomposition. We compute a new matrix Y Ã 5 YP 0 . The resulting matrix Y Ã has the desired correlation (r). Then, we sort X's columns independently to have the same rank ordering as Y Ã by reordering X's entries based on the rank orders in Y Ã as described in Iman and Conover. 27 Thus, the columns in the resulting matrix X Ã will have the same rank (Spearman) correlation coefficient as Y Ã and preserve the marginal distributions of the jth and kth QoL weights. For each inner loop iteration, we compute the percentage of samples violating the preference ordering defined by q j; k . If the percentage of violations is less than E, we decrement r by D. We repeat step 2b until the sample violations reach our prespecified threshold E or r equals 0. We then record the correlation c j; k 5 r in matrix C and move to the next pair of health states in the outer loop (2a). After finishing all pairwise combinations, we proceed with step 3.
Step 3: After calculating all desired pairwise correlations in C, we sort the vectors in U and obtain the matrix U Ã , which approaches the goal of avoiding preference order violations while preserving the marginal univariate uncertainty distributions of all the QoL weight vectors combined. This process closely follows step 2b. However, unlike S, we cannot always use C directly as it is not guaranteed to be positive and definite (required to be used as a correlation matrix), and hence its Cholesky decomposition may not be feasible. Therefore, we first compute the eigenvalues (B) and eigenvectors (V) for C, set any of eigenvalues 0 in B equal to a very small positive number (e.g., 0.0001) to produce B Ã , and compute the adjusted correlation matrix C Ã 5 VB Ã V À1 . Again, we express C Ã as MM#, using the Cholesky decomposition to compute M. Then, we sort the columns in the reference matrix (R) and compute R Ã 5 RM 0 . Finally, we sort the columns in U independently to have the same rank as the columns in R Ã . 27 The sorted utility matrix U Ã minimizes preference order violations while maximizing the joint uncertainty among the QoL weights and approaches the other desired properties. Since this step may impose a new ordering of the values within the QoL weight vectors, analysts are encouraged to check the percent sample violations before and after this step to ensure that the algorithm meets the specified limits and, if not, to adjust tolerance thresholds, distributional assumptions, or both before rerunning the algorithm. In practice, the analyst must choose a value for E, the proportion of samples allowed to violate the preference ordering. The choice can be arbitrarily small, and using 1% or 0.1% could be quite reasonable in many applications, although for smaller values of E, the analyst must start with a larger number of PSA samples. Furthermore, in situations where the analyst feels that the marginal distributions are much more uncertain than the preference ordering, it is possible to use a very small E and then, in a postprocessing step after using our algorithm, drop any samples violating the preference order with minimal changes to the marginal given that such a small fraction of samples is dropped. Our approach may prove more efficient than rejection sampling methods used alone, especially for complex preference ordering and computationally expensive models, given that it may reject fewer candidate samples.
Example Models Used for Methods Comparison
We compare our method with uncorrelated distributions, rejection sampling, altering marginal distributions, and cross-sorting (Table 1) . We focus on these methods because they do not fix correlation at an arbitrary assumed level, as the underlying correlation structure is generally highly uncertain. We compare these methods using 2 decision-analytic models described below.
Example model 1: The first is a simple decision tree for a hypothetical disease with health states of mild and moderate complications. The decision is between a less expensive and less effective ''drug A'' and ''drug B'' (see Appendix B for further details). While we are uncertain about the QoL weights for mild and moderate complications. We explore potential bias in PSA and VOI depending on the method used to form the joint uncertainty distribution for QoL weights under 3 prior information scenarios: high uncertainty, moderate uncertainty, and low uncertainty, in which the expected values of the QoL weights remain the same but the standard errors are progressively smaller (see Appendix Table B1 ). Figure 2 illustrates the relationship of uncertainty and correlation on preference order violations for the QoL weights of mild and moderate. At low correlation and high uncertainty, the proportions of violations (points above the orange line) are the highest. Increasing the correlation substantially reduces these violations, which is the core of our approach.
Example model 2: The second is a previously published Markov model of chronic hepatitis C virus (HCV) infection. 24 Briefly, the model tracks individuals with chronic genotype 1 HCV monoinfection and with an initial level of liver fibrosis quantified in terms of Metavir score F0 to F4. Liver fibrosis can progress toward advanced liver disease, including decompensated cirrhosis, hepatocellular carcinoma, and liver transplantation. More advanced liver disease lowers QoL and increases mortality. Treatment leading to sustained virologic response (SVR) arrests liver progression, improves QoL and survival, and reduces medical costs. In our example, the model involves uncertainty about the QoL weights for 9 health states (defined in terms of fibrosis and SVR), a preference ordering in which some health states are not known to be unambiguously better than others (e.g., whether SVR after F4 fibrosis is better or worse than F2 fibrosis without SVR). The model involves a decision between 3 treatment alternatives: no treatment, dual therapy with pegylated interferon and ribavirin, and triple therapy involving boceprevir along with pegylated interferon and ribavirin. While newer HCV treatments are available, we do not include them to aid in simplicity of exposition.
Assessing Performance
We compare each method's performance with each example model using the following procedure.
PRESERVING HEALTH STATE RANK ORDER IN PROBABILISTIC ANALYSES
We start by comparing methods simultaneously using 2 performance metrics: 1) the proportion of samples violating preference orderings and 2) changes to the marginal distributions. We compute the first metric by determining the average percent violations over all pairs of health states. For the second metric, we use the Kolmogorov-Smirnov (K-S) statistic to quantify, for each health state, the absolute difference between the empirical cumulative density function (ECDF) of the prespecified marginal distribution and the ECDF implied by the samples produced by each method. The K-S statistic is equal to zero if the distribution does not change and equal to 1 if the method changes the distribution. For both metrics, we subtract the values computed from 1 to generate a measure of fidelity [0, 1] where higher values imply greater fidelity.
We then evaluate how each method's performance on these 2 metrics changes with different amounts of uncertainty reflected in the marginal distributions (i.e., the 3 uncertainty scenarios listed above for example model 1 (see Appendix Table B1 ).
Finally, we evaluate how each method's fidelity to preference ordering and the marginal distributions altered its PSA estimates (i.e., the likelihood of a given strategy being cost-effective at a given willingness-topay threshold and the expected incremental net monetary benefit [EINMB] of a strategy and the uncertainty of the EINMB estimate) and expected value of partial perfect information (EVPPI) estimates (i.e., the value one could expect to gain by eliminating uncertainty about a parameter). For PSA, we considered 2 measures because prior research has noted that the first measure of likelihood of a strategy being optimal does not capture how much better a strategy is when it is optimal. 28 We hypothesized that both preference order violations and changes to marginal uncertainty distributions from the various methods would bias the PSA and EVPPI results in complex ways. For both the PSA and EVPPI, we used 10,000 samples, and to ensure that comparisons of methods were not due to randomness, we used the same random seed to draw PSA samples to which each method was applied.
Making the Approach Accessible
To support external evaluation of our method and its wider use in decision models and costeffectiveness analyses, we implemented versions for MATLAB (MathWorks, Natick, MA) and R (R Core Team, Vienna, Austria). Code is provided in Appendixes C1 and C2. All implementations take as inputs the independent QoL matrix (U) and the preference rank ordering matrix (Q) and output the sorted matrix U Ã of the PSA samples. The rows of U Ã represent the PSA samples, and the columns represent the QoL weights for the health states. This facilitates import into programs such as TreeAge Pro (TreeAge Software, Williamstown, MA) (see Appendix D for detailed instructions).
RESULTS
Our method maintains high fidelity to the univariate marginal distributions for QoL weights while simultaneously producing few preference order violations for both example model 1 and example model 2 ( Figure 3A,B) . As expected, the existing methods either maintain fidelity to the marginal distributions at the expense of violating preference order (uncorrelated distributions) or else avoid violations at the expense of changing marginal distributions (rejection sampling, altering marginal distributions, and crosssorting). While our method performs better on all metrics used, existing methods, particularly altered margins, may actually perform worse than the fidelity metric suggests because altered margins can shift the tails of the distribution more than the middle in a way that the K-S statistic is less sensitive to.
Our method's performance advantages are larger when the uncertainty reflected in the univariate marginal distributions is higher ( Figure 3C ). While all methods evaluated had greater difficulty simultaneously maintaining fidelity to the marginal distributions and keeping violation rates low when uncertainty was high, the existing methods had substantially larger performance degradations in the presence of higher uncertainty.
For PSA, failure to maintain fidelity to marginal distributions altered the fraction of times a strategy was considered optimal and sometimes resulted in different conclusions about which strategy was most cost-effective. For example model 1 (at a willingness-to-pay [WTP] of $50,000/QALY for illustration), all methods suggest that drug B is preferred to drug A. However, the percentage of simulations in which B is preferred to A varies from 56% to 93%. In addition, the EINMB also varies from $146 to $793, indicating that the results of PSA vary substantially depending on the method chosen to avoid preference order violations (Table 3 , upper panel). The EINMB of drug B is higher than that of drug A under all methods, although our method and the uncorrelated distribution are closest to the increment net monetary benefit (INMB) (computed by setting all parameters to their mean values [i.e., $150]). Likewise, the standard deviation of the EINMB tends to be underestimated in the existing methods. For example model 2, the 2 methods that are faithful to the marginal distributions estimate a greater likelihood that ''triple therapy with boceprevir'' is preferred (WTP = $44,000/QALY for illustration) relative to the existing methods that suggest that dual therapy is most likely optimal ( Table 3 , lower panel). This result is driven by the fact that the existing methods tend to estimate an EINMB for boceprevir that is lower (and more certainly so) than the methods that are faithful to the marginal distributions.
For EVPPI, violating preference ordering and altering the original marginal distributions resulted in existing methods generally biasing the estimates of value of seeking additional information. For example model 1, the uncorrelated distributions method, which permits a substantial proportion of preference order violations and implies that information gained about one parameter does not provide information about other parameters, overestimated EVPPI for all QoL weights (Table 4 ). In contrast, methods that reduced preference order violations at the expense of the fidelity to the marginal distributions suggested that there was lower but nonzero value to obtaining additional information about either QoL weight. Notably, the bias of existing methods compared with that estimated with the induced correlations method can go either way. For the multiple health Figure 3 Performance comparison of our method (induced correlations) to existing methods for capturing the joint uncertainty distribution of quality-of-life (QoL) weights. Panels A and B compare the performance of our approach (induced correlations) to 4 other approaches involving avoiding preference rank-order violations for example mode1 and example model 2, respectively. Performance involves simultaneous assessment on 2 different scales: 1) the percentage of samples violating the preference rank order with each method (x-axis) and 2) how much the cumulative density functions (CDFs) of the QoL weight uncertainty distributions change with each method compared with the specified marginal distributions without correlation (y-axis). The optimal point (no rank violations and no difference in CDF) is marked with the arrow. Our approach does not change the marginal distribution (0 CDF violations) and induces approximately 5% sample violations as per the epsilon we set, which can be made arbitrarily small. Panel C shows the effect of increased uncertainty on these performance metrics for example model 1. As expected, the performance of all methods improves when uncertainty is low, as shown by the proximity of all methods to the optimal point indicated by the arrow. Our approach continues to perform relatively well even at higher uncertainty levels where existing methods' performance tends to degrade appreciably. K-S, Kolmogorov-Smirnov.
states considered in example model 2 (Appendix E), EVPPI estimates differed with generally higher values for uncorrelated distributions, while for other health states, existing methods produced lower EVPPI estimates than the induced correlations method.
While the EVPPI values estimated in both examples were relatively small for all methods, they represent the value of obtaining information for each affected patient-the relevant quantity for assessing whether there is insufficient value to obtain additional information is the analogous population EVPPI. For example, if there are 100,000 patients (discounted to present net value) who could benefit from improving information and the cost of a study to obtain information were $300,000, then in example model 1, one would correctly conclude that there is insufficient value to obtain this information only using the following methods: our method, cross-sorting, or rejection sampling. This is because the population EVPPI estimates for either health state for these methods is below $300,000. A similar example with the same study cost but with 1,000,000 patients for example model 2 shows that whereas our method (along with uncorrelated distributions and altering margins) would suggest the possibility that obtaining additional information may be sufficiently valuable, cross-sorting and rejection sampling incorrectly conclude that there is insufficient value to obtaining additional information (Appendix E).
DISCUSSION
PSAs and VOI analyses are powerful tools that are increasingly used and required by journals. Methods to ensure that they are free from bias are therefore of growing importance. While it is difficult in general to specify correct joint uncertainty distributions for all model parameters, for QoL weights of health states, preference orderings over those states can inform their unbiased joint uncertainty distribution (e.g., it is certain that states like ''healthy'' should have higher QoL weights than states like ''diseased'' in all PSA and VOI samples).
We developed a method that achieves this goal without distorting the univariate marginal uncertainty distributions specified for the QoL weight of each state. The comparison of our method to existing alternative methods shows that ours performs best in terms of simultaneously avoiding preference order violations while remaining faithful to the marginal distributions. Furthermore, we used 2 example models to show that these differences can matter for both PSA and VOI estimates. To ensure that the results of our analyses are mostly driven by variations in the methods and not simply due to randomness, we repeated the analysis of method performance for both example model 1 and example model 2 one hundred times using different random seeds (Appendix F). The variations in the results were very small over the PSA analyses, almost entirely attributable to the methods rather than to chance alone. To enable further assessment by researchers and ease adoption by analysts, we provide Open Source implementations of our method in MATLAB and R.
Our approach has a number of other advantages. It is not limited by the number of model health states it can accommodate, by restrictions on the types of marginal uncertainty distribution used for QoL weights, or by what correlations patterns it can incorporate. It runs quickly because its Open Source implementation employs commonly used, high-performance languages and because its algorithm relies on simple sorting, univariate optimization, and closed-form solutions. In addition, the iterations in the outer loop could be executed on parallel computer processing threads to further increase efficiency. Finally, it is possible to employ our method along with linear regression meta-modeling or other emulator techniques to update previously run PSAs that use existing methods to establish their joint uncertainty distributions even without access to the original model as long as one has access to a set of PSA results (sampled parameter values to provide the univariate marginals and corresponding costs and effects for each intervention considered). [29] [30] [31] [32] Our study contributes to existing work on specifying uncertainty distributions for PSA and VOI that has been highlighted by recent best practice guidelines. 3 Influential work by Briggs and others 20 has helped to define the rationale for standard parametric forms primarily for univariate marginal distributions for many parameter types. For joint distributions, Ades and Lu 10 have developed Markov chain Monte Carlo (MCMC) estimation techniques, although current performance and convergence challenges of MCMC may hinder its widespread adoption. In other fields, researchers use copula methods to fit joint distributions that are constrained by their marginal. However, these methods are best suited to cases when one wishes to recover a joint distribution based on points that have been generated by the true distribution. 21 Primarily for joint distributions of natural history and intervention effectiveness parameters, health analysts use empirical calibration, although it is still not commonly practiced. 14, 16, 22 One challenging case is of parameters describing behaviors that may be correlated (e.g., uncertainty distributions about average levels of condom use, needle sharing, seeking human immunodeficiency virus testing, and adhering to antiretroviral therapy treatment may be correlated). Recent work has begun to use empirical calibration for multiple risk behaviors (e.g., starting and quitting smoking). 17 Techniques that use Bayesian updating or other approaches to characterize joint uncertainty of several parameters (e.g., the bivariate normal distribution) have been described for test sensitivity and specificity and for correlated treatment effect estimates. 23 Although the motivation for our study is the joint uncertainty of QoL weights, it could be applied more generally to other parameters where there is agreement about the ordering of variable values. For example, the joint uncertainty distribution of some cost or probability parameters could be characterized using our method.
Our method has limitations. First, similar to existing methods, parameters outside of these QoL weights are assumed independent. While we believe going from independent univariate to joint uncertainty for groups of parameters most likely reduces bias in PSA and VOI, it could potentially increase bias relative to estimates from independent univariate distributions. Future theoretical and numerical simulation work could shed light on this area. Second, our method is not the only way to maintain marginal distributions while respecting preference orderings, and hence, in some cases, alternative approaches may identify joint distributions that better reflect the uncertainty in combinations of parameters. Imagine a bivariate case in which the QoL weight of the less preferred state is on the y-axis and the more preferred state is on the x-axis. In addition to limiting violations in the northwest corner, our approach also reduces the number of samples that occupy the far southeast corner of the parameter space (see Figure 1 ). Although other approaches could, in theory, produce joint distributions that occupy a greater portion of this southeast corner (or their higher dimensional analogs), in numerical experiments, we have noted convergence challenges in fitting these types of joint distributions while respecting the marginal distributions. In addition, we believe that analysts may find limiting the samples in the far southeast corner desirable. This is simply because it limits extreme differences in QoL weights between the compared states by avoiding samples in which the better state is assigned an extremely high QoL weight while the less preferred state is assigned an extremely low QoL weight. While our study considered both a simple 2-state Markov model and a more complex published example showing in both that uncorrelated QoL weights could influence results, it will be important to evaluate how much such biases influence results across a range of real-world applications. Finally, in some applications, even with Open Source implementations available, analysts may reasonably consider the tradeoff between simplicity of method and description versus accuracy of results when selecting the best method for their particular application.
Recent guidelines highlight the importance of ensuring that distributions used for PSA and VOI analyses reflect the true joint uncertainty of model parameters to avoid bias. 3 We developed a practical method for capturing the joint uncertainty of QoL weights that reflects their specified marginal distributions while respecting the preference rank order of their corresponding health states; the method outperforms existing methods for addressing this challenge. Analysts should consider employing our method to reduce bias in PSA and VOI estimates given our findings and the availability of an Open Source implementation.
